BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9221630)

  • 1. [Basedow disease hyperthyroidism--is there a therapeutic standard? Conservative therapy].
    Schumm-Draeger PM
    Zentralbl Chir; 1997; 122(4):224-6. PubMed ID: 9221630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
    Schumm-Draeger PM
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug treatment of immune hyperthyroidism (Basedow disease). Patient selection, long-term follow-up and prevention of recurrence].
    Quadbeck B; Hörmann R; Janssen OE; Mann K
    Internist (Berl); 2003 Apr; 44(4):440-8. PubMed ID: 12914401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine.
    Hoermann R; Quadbeck B; Roggenbuck U; Szabolcs I; Pfeilschifter J; Meng W; Reschke K; Hackenberg K; Dettmann J; Prehn B; Hirche H; Mann K;
    Thyroid; 2002 Dec; 12(12):1119-28. PubMed ID: 12593726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F; González-Ortiz M; Durón H; Sánchez C
    Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessment of antithyroid drug therapy of Graves' disease.
    Feldt-Rasmussen U; Glinoer D; Orgiazzi J
    Annu Rev Med; 1993; 44():323-34. PubMed ID: 7682804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment.
    Vitti P; Rago T; Chiovato L; Pallini S; Santini F; Fiore E; Rocchi R; Martino E; Pinchera A
    Thyroid; 1997 Jun; 7(3):369-75. PubMed ID: 9226205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission.
    García-Mayor RV; Páramo C; Luna Cano R; Pérez Mendez LF; Galofré JC; Andrade A
    J Endocrinol Invest; 1992 Dec; 15(11):815-20. PubMed ID: 1283984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Graves' disease--antithyroid drug therapy].
    Onaya T
    Nihon Rinsho; 1999 Aug; 57(8):1846-50. PubMed ID: 10483263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reflections on the therapeutic goal in Basedow hyperthyroidism].
    Höfer R
    Acta Med Austriaca; 1987; 14(3-4):70-2. PubMed ID: 2447737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hyperthyroidism with antithyroid drugs].
    Eber O
    Acta Med Austriaca; 1995; 22(5):83-90. PubMed ID: 8651042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Basedow disease with synthetic antithyroid drugs. Evaluation of the dose on the efficacy of the long term treatment].
    Leclere J
    Ann Endocrinol (Paris); 1994; 55(1):11-4. PubMed ID: 7528485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of hyperthyroidism due to Graves' disease in Japan in 1988. The Japan Thyroid Association.
    Nagayama Y; Izumi M; Nagataki S
    Endocrinol Jpn; 1989 Apr; 36(2):299-314. PubMed ID: 2476301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves' disease.
    van Soestbergen MJ; van der Vijver JC; Graafland AD
    J Endocrinol Invest; 1992 Dec; 15(11):797-800. PubMed ID: 1283983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.